510(k) K103531
K103531 is an FDA 510(k) premarket notification submitted by Tokyo Boeki Medisys, Inc. for the device "PRESTIGE 24I; BIOLIS 24I; MGC 240". The FDA issued a decision of Substantially Equivalent on December 1, 2011. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Tokyo Boeki Medisys, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 1, 2011
- Date Received
- December 1, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type